Bone marrow endothelial progenitors are defective in systemic sclerosis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Arthritis & Rheumatism

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.22035PMID 16868984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin".

  2010cited by this paper
• Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.

  2005cited by this paper
• Endothelial progenitor cells for vasculogenesis.

  2005cited by this paper
• Circulating endothelial progenitor cells and cardiovascular outcomes.

  2005cited by this paper
• Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane

  2005cited by this paper
• Scleroderma: from cell and molecular mechanisms to disease models.

  2005cited by this paper
• CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure

  2004cited by this paper
• Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.

  2004cited by this paper
• Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

  2004cited by this paper
• Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance

  2004influential reference
• Defective vasculogenesis in systemic sclerosis.

  2004cited by this paper
• Phenotypic and Molecular Characterization of Bone Marrow L-NGFR + Mesenchymal Stem Cells.

  2004cited by this paper
• Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.

  2004cited by this paper
• Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

  2004cited by this paper
• Elevated vascular endothelial growth factor in systemic sclerosis.

  2003cited by this paper
• Mesenchymal Progenitor Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Rat Cellular Cardiomyoplasty Model

  2003cited by this paper
• In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells.

  2003cited by this paper
• The vasculopathy of Raynaud's phenomenon and scleroderma.

  2003cited by this paper
• European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

  2003cited by this paper
• Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

  2003cited by this paper
• Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies.

  2002influential reference
• Deficient Smad7 expression: A putative molecular defect in scleroderma

  2002cited by this paper
• Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

  2002cited by this paper
• Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy

  2002cited by this paper
• Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

  2002cited by this paper
• Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells

  2001cited by this paper
• Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

  2001cited by this paper
• Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells

  2001cited by this paper
• Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction

  2001cited by this paper
• Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

  2001cited by this paper
• European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes

  2001cited by this paper
• Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95.

  2000cited by this paper
• Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

  2000cited by this paper
• Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells

  2000cited by this paper
• Circulating endothelial cells in vascular disorders: new insights into an old concept

  2000cited by this paper
• Vascular function in systemic sclerosis

  2000cited by this paper
• Circulating endothelial precursors: mystery, reality, and promise.

  2000cited by this paper
• Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate

  1999cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma.

  1998cited by this paper
• Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis.

  1998cited by this paper
• SYSTEMIC SCLEROSIS : A Vascular Perspective

  1996cited by this paper
• Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis.

  1995cited by this paper
• Rapidly Forming Apatitic Mineral in an Osteoblastic Cell Line (UMR 10601 BSP) (*)

  1995cited by this paper
• Isolation and characterization of microvascular endothelial cells from the adult human dermis and from skin biopsies of patients with systemic sclerosis.

  1994cited by this paper
• Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset.

  1992cited by this paper
• Mesenchymal Stem Cells

  1991cited by this paper
• Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma.

  1991cited by this paper
• The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.

  1989cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

  1984cited by this paper
• Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper

• Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis

  2025cites this paper
• What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review.

  2024cites this paper
• Endothelial Dysfunction in Systemic Sclerosis

  2023cites this paper
• Microangiopathy in Rheumatic Diseases

  2023cites this paper
• Extracellular Matrix Glycoprotein Thrombospondin 1: An Overlooked Pathological Mediator in Vasculopathy of Systemic Sclerosis-Secondary Raynaud’s Phenomena

  2023cites this paper
• Endothelial Progenitor Cells in Autoimmune Disorders

  2023cites this paper
• State-of-the-art Techniques for Imaging the Vascular Microenvironment in Craniofacial Bone Tissue Engineering Applications.

  2022cites this paper
• Endoglin and Systemic Sclerosis: A PRISMA-driven systematic review

  2022cites this paper
• Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases

  2022cites this paper
• Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis

  2022cites this paper
• Study of the Phenotype of Endothelial Cells in the Vessels of Uveal Melanoma

  2022cites this paper
• Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches

  2022cites this paper
• Oral Mesenchymal Stromal Cells in Systemic Sclerosis: Characterization and Response to a Hyaluronic-Acid-Based Biomaterial

  2021cites this paper
• Nondigital Skin Ulcers in Systemic Sclerosis: A Neglected Entity

  2021cites this paper
• Endocan and Circulating Progenitor Cells in Women with Systemic Sclerosis: Association with Inflammation and Pulmonary Hypertension

  2021cites this paper
• Mesenchymal stromal cells for systemic sclerosis treatment.

  2021cites this paper
• Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients

  2021cites this paper
• Treatment of atherosclerosis through transplantation of endothelial progenitor cells overexpressing dimethylarginine dimethylaminohydrolase (DDAH) in rabbits.

  2021cites this paper
• Mesenchymale Stammzelltherapie bei Autoimmunerkrankungen

  2020cites this paper
• Human umbilical cord mesenchymal stem cells ameliorate skin fibrosis development in a mouse model of bleomycin-induced systemic sclerosis

  2020cites this paper
• Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis

  2020cites this paper
• Incomplete Differentiation of Engrafted Bone Marrow Endothelial Progenitor Cells Initiates Hepatic Fibrosis in the Rat

  2019cites this paper
• Insights into Inflammatory Priming of Adipose-Derived Mesenchymal Stem Cells: Validation of Extracellular Vesicles-Embedded miRNA Reference Genes as A Crucial Step for Donor Selection

  2019cites this paper
• Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis

  2019cites this paper
• Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling

  2019cites this paper
• The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis

  2019cites this paper
• Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases.

  2019cites this paper
• Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis.

  2019cites this paper
• 7 The Promise of Hematopoietic Stem Cell Therapy for Stroke : Are We There Yet ?

  2018cites this paper
• Combining autologous bone marrow mononuclear cells seeded on collagen sponge with Nano Hydroxyapatite, and platelet-rich fibrin: Reporting a novel strategy for alveolar cleft bone regeneration.

  2018cites this paper
• Supportive Use of Adipose-Derived Stem Cells in Cell-Assisted Lipotransfer for Localized Scleroderma

  2018cites this paper
• Bone marrow derived endothelial progenitor cells retain their phenotype and functions after a limited number of culture passages and cryopreservation

  2018cites this paper
• The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis

  2018cites this paper
• Chapter 2 Atherosclerosis and Cardiovascular Risk in Systemic Sclerosis

  2018cites this paper
• Vascular Mechanisms of Systemic Sclerosis

  2018cites this paper
• Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?

  2018cites this paper
• EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

  2018cites this paper
• Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective

  2017cites this paper
• The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.

  2017cites this paper
• Chapter 83 – Etiology and Pathogenesis of Scleroderma

  2017cites this paper
• Adipose-Derived Cell Transplantation in Systemic Sclerosis: State of the Art and Future Perspectives

  2017cites this paper
• Atherosclerosis and Cardiovascular Risk in Systemic Sclerosis

  2017cites this paper
• Phenotypical and Functional Characteristics of in Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells from Patients with Systematic Sclerosis

  2017cites this paper
• Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis

  2017cites this paper
• Use of Lipotransfer in Scleroderma

  2017cites this paper
• Increased serum levels of fractalkine and mobilisation of CD34+CD45− endothelial progenitor cells in systemic sclerosis

  2017cites this paper
• Hybrid composites of mesenchymal stem cell sheets, hydroxyapatite, and platelet-rich fibrin granules for bone regeneration in a rabbit calvarial critical-size defect model

  2017cites this paper
• A review of the effects of statins in systemic sclerosis.

  2016cites this paper
• Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation

  2016cites this paper
• Endothelial Progenitor Cells

  2016cites this paper
• Recent updates in experimental protocols for endothelial cells

  2016cites this paper
• Intrinsic Deregulation of Vascular Smooth Muscle and Myofibroblast Differentiation in Mesenchymal Stromal Cells from Patients with Systemic Sclerosis

  2016cites this paper
• Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.

  2016cites this paper
• Atherosclerosis in Psoriatic Arthritis: A Multiparametric Analysis Using Imaging Technique and Laboratory Markers of Inflammation and Vascular Function

  2016cites this paper
• Update on mesenchymal stem cell-based therapy in lupus and scleroderma

  2015cites this paper
• Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets

  2015cites this paper
• Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage?

  2015cites this paper
• Cytokines in the immunopathology of systemic sclerosis

  2015cites this paper
• Cardiovascular disease in systemic sclerosis.

  2015cites this paper
• Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies.

  2015cites this paper
• Cellular interactions in the pathogenesis of interstitial lung diseases

  2015cites this paper
• Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis.

  2015cites this paper
• Brief Report: Impaired In Vivo Neovascularization Capacity of Endothelial Progenitor Cells in Patients With Systemic Sclerosis

  2014cites this paper
• Endothelial progenitor cell biology in ankylosing spondylitis

  2014cites this paper
• Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor

  2014cites this paper
• Stem Cells for Neurovascular Repair in CNS Trauma

  2014cites this paper
• Vascular Mechanisms in CNS Trauma

  2014influential citation
• Systemic Sclerosis, Scleroderma

  2014cites this paper
• Rosuvastatin Improves Endothelial Progenitor Cells in Rheumatoid Arthritis

  2014cites this paper
• Endothelial progenitor cell biology in psoriatic arthritis patients in the absence of traditional cardiovascular risk

  2014cites this paper
• Alterations of ROS pathways in scleroderma begin at stem cell level.

  2013cites this paper
• Мезенхимальные клетки костного мозга -перспективы использования при ревматических болезнях

  2013cites this paper
• Mesenchymal stem cell transplantation in multiple sclerosis.

  2013cites this paper
• The role of Microsomal prostaglandin synthase-1 (mPGES-1) and Ephrin B2 in Scleroderma

  2013cites this paper
• Bone marrow rejuvenation accelerates re-endothelialization and attenuates intimal hyperplasia after vascular injury in aging mice.

  2013cites this paper
• [Roles of aberrant endothelial progenitor cells in pathogenesis of systemic sclerosis].

  2013cites this paper
• Neurologic involvement in scleroderma: a systematic review.

  2013cites this paper
• 83 – Etiology and Pathogenesis of Scleroderma

  2013cites this paper
• Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis.

  2013cites this paper
• Stem Cells for Neurovascular Repair in Stroke.

  2013cites this paper
• Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis

  2013cites this paper
• Peroxisome proliferator‐activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts

  2013cites this paper
• Platelet gel in the treatment of severe scleroderma skin ulcers

  2012cites this paper
• T cell abnormalities in systemic sclerosis with a focus on Th17 cells.

  2012cites this paper
• Angiogenesis and Vasculopathy in Systemic Sclerosis: Evolving Concepts

  2012cites this paper
• Multiphasic Roles for TGF-Beta in Scarring: Implications for Therapeutic Intervention

  2012cites this paper
• Is There Evidence for Vasculitis in Systemic Sclerosis?

  2012cites this paper
• Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.

  2012cites this paper
• The immunomodulatory capacity of mesenchymal stem cells.

  2012cites this paper
• Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols

  2012cites this paper
• Pathogenesis of the Endothelial Damage and Related Factors

  2012influential citation
• The Promise of Hematopoietic Stem Cell Therapy for Stroke: Are We There Yet?

  2012cites this paper
• The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

  2012cites this paper
• Etiopathogenesis of systemic sclerosis

  2012cites this paper
• Angiogenic cytokines and growth factors in systemic sclerosis.

  2011cites this paper
• Bone marrow stem cell mobilization in stroke: a ‘bonehead’ may be good after all!

  2011cites this paper
• Autologous Mesenchymal Stem Cells Foster Revascularization of Ischemic Limbs in Systemic Sclerosis

  2011cites this paper
• Induction of apoptosis in circulating angiogenic cells by microparticles.

  2011cites this paper
• Vascular Changes in Bleomycin-Induced Scleroderma

  2011cites this paper
• Coagulation and autoimmunity in scleroderma interstitial lung disease.

  2011cites this paper